Skip to main content
Livermore
Livermore
ZHEN

Arlington Partners LLC

SEC CIK
0001389848
Latest filing
Jul 7, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Arlington Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
6,777
Value
$324.9K
% of portfolio
0.6%
Quarters held
21
Since Q1 2021
Holdings of NVO by Arlington Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,777$324.9K0.6%+283+4.4%AddedHolders
Q1 20266,494$238.7K0.5%+6,494NewHolders
Q4 20250$00.0%−93,006−100.0%Sold outHolders
Q3 202593,006$5.16M1.8%+26,928+40.8%AddedHolders
Q2 202566,078$4.56M1.7%+16,733+33.9%AddedHolders
Q1 202549,345$3.43M1.3%+19,933+67.8%AddedHolders
Q4 202429,412$2.53M1.0%00.0%UnchangedHolders
Q3 202429,412$3.50M1.4%+5,935+25.3%AddedHolders
Q2 202423,477$3.35M1.7%−3,680−13.6%ReducedHolders
Q1 202427,157$3.49M1.8%−3,018−10.0%ReducedHolders
Q4 202330,175$3.12M0.9%−1,177−3.8%ReducedHolders
Q3 202331,352$2.85M1.2%+3,930+14.3%AddedConverted for a 2-for-1 splitHolders
Q2 202313,711$2.22M0.3%00.0%UnchangedHolders
Q1 202313,711$2.18M0.3%−6,275−31.4%ReducedHolders
Q4 202219,986$2.70M0.4%00.0%UnchangedHolders
Q3 202219,986$1.99M0.8%+323+1.6%AddedHolders
Q2 202219,663$2.19M0.7%−4,992−20.2%ReducedHolders
Q1 202224,655$2.74M0.8%−3,676−13.0%ReducedHolders
Q4 202128,331$3.17M0.9%−3,957−12.3%ReducedHolders
Q3 202132,288$3.10M0.9%−10,644−24.8%ReducedHolders
Q2 202142,932$3.60M1.2%+1,003+2.4%AddedHolders
Q1 202141,929$2.83M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.